Trial
NCT01163942
Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF)
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
European Society for Blood and Marrow Transplantation
Collaborators
Sanofi
Condition
Aplastic Anaemia
Intervention
G-CSF
Why stopped
Ceased production of the study drug, Lymphoglobulin. Recruitment of patients onto the trial was too slow.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-24